Category Archives: Genetics

Animal Genetics Market Forecast to 2027 – COVID-19 Impact and Global Analysis By Product, Genetic Material, and Services and Geography. – Yahoo…

TipRanks

Volatility is back on the menu. Last week brought Januarys trading to a close in what amounted to the stock markets worst month since October. The GameStop saga hogged the headlines as the retail buying frenzy for names with high short interest raised the possibility the market might be exhibiting bubble behavior. Add into the mix the slow rollout of Covid-19 vaccines and the fear of a delayed return to normalcy, and once again, uncertainty is engulfing Wall Street. The key to success in this environment is really the same as in normal times. Look for stocks with sound fundamentals and a history of success. Yes, past performance is no guarantee of future returns, but a history of share price growth is a good indicator. After all, growth stocks are growing for a reason. Weve used the TipRanks database to pull up the details on three such growth stocks that have shown sustained gains over the past year gains of 120% or more. And even better, for investors seeing a growth profile, Wall Streets analysts see continued growth ahead. Hyrecar, Inc. (HYRE) The gig economy has exploded in recent years, connecting people with skills to people with needs. Hyrecar fills a gap for car-less drivers, connecting car owners with idle vehicles to gig drivers (think Uber and Lyft) who need a vehicle. The Hyrecar service allows drivers to rent time in these vehicles, earning money from their transport or delivery routes while the cars owner earns a passive income from the rental fee. Hyrecar operates on the peer-to-peer model, and is available to subscribers as an online platform or a mobile app. In the past year 12 months, the companys shares have boomed. HYRE is up 228% in that time, riding especially high as economies opened up in 2H20. To put some numbers on the companys gains, revenue increased from $3.7 million in 3Q19 to $6.8 million in 3Q20 (the last reported quarter), a year-over-year gain of 83%. While Hyrecar currently runs a net loss like many tech-oriented startups that loss has moderated over the course of 2020. In 3Q19, EPS was negative 24 cents; in 3Q20, that had improved to negative 10 cents. In January 2021, the company announced partnerships with AmeriDrive Holdings, an automotive fleet manager, and Cogent Banks Specialty Lending Unit to increase the pool of available vehicles. The expected surge in vehicle availability has analysts bullish on Hyrecar. New strategic partnerships involving HYRE and four key players, including AmeriDrive Holdings (private) and Cogent Bank (private), aims to more than double the vehicle supply on HYREs platform in the next 12-18 months We view the announcement as a significant win for HYRE, which we believe creates a massive opportunity for HYRE to increase average active rentals to ~9,000 per day vs. ~2,800 in 2021, Maxim analyst Jack Vander Aarde noted. In line with this upbeat outlook, the 5-star analyst puts a Buy rating on HYRE along with an $18 price target. At that level, his target predicts an 82% upside in the coming year. (To watch Vander Aardes track record, click here) Over the past 3 months, only two other analysts have thrown the hat in with a view on the carsharing services player. The two additional Buy ratings provide HYRE with a Strong Buy consensus rating. With an average price target of $15.67, investors stand to take home a 59% gain, should the target be met over the next 12 months. (See HYRE stock analysis on TipRanks) Alpha and Omega Semiconductor (AOSL) Next up, Alpha and Omega, is a semiconductor maker with a wide portfolio of chipsets specifically designed for the power control requirements of advanced electronic devices. AOSLs chips are found in a range of common devices, including flat-screen TVs, LED lighting, portable PCs, smart phones and the power supply units for these products. In the fiscal 1Q21, the company reported $151.6 million in revenue, for a 28% year-over-year increase. Earnings, which had been negative prior to the fiscal Q1 report, turned positive with an EPS of 36 cents. The gain bodes well for the companys performance, now that the pandemic crisis is starting to recede. The second fiscal quarter results will be published on Thursday, February 4. Alpha and Omegas stock performance is also picking up, with shares rising 123% over the past 12 months. Growth like this is sure to attract attention, and it has. 5-star analyst Craig Ellis of B. Riley Securities, noted, Comms YE 5G smartphone unit strength lends an upside bias, and we like CY21s 2x YY growth potential... In Consumer, healthy next-gen gaming console uptake has follow-on product and design-in opportunities. So, we believe Comms, Compute, and Consumer end markets are performing quite well We expect above-industry AOSL growth" To this end, Ellis rates AOSL a Buy along with a $40 price target. This figure implies ~40% upside from current levels. (To watch Ellis track record, click here) Though not many have weighed in with an opinion on AOSL in the last 3 months, those who have are singing its praises. Overall, two analysts rate the semiconductor maker a Buy and the average price target of $37.50 implies ~30% upside for the upcoming year. (See AOSL stock analysis on TipRanks) Lands End (LE) The retail landscape has been shifting dramatically in recent years, and many venerable names have fallen by the wayside. Some, however, have survived. Lands End, founded almost 60 years ago, has built a reputation for quality in the clothing, footwear, and home dcor niche. The company brought in $1.45 billion for its fiscal year 2019, the last with full numbers available. From the 2020 numbers that have been published, it looks like Lands End is on track for steady growth. It posted year-over-year revenue gains in both Q2 and Q3 of 2020, indicating a quick recovery from the COVID crisis. The Q3 revenue was $360 million, up 5.8% from 3Q19 and up an even more impressive 15% from 2Q20. Meanwhile, the company has revised its Q4 guidance upward. Revenue is expected between $528 million and $533 million, up 4% at the midpoint. EPS is expected between 54 cents and 58 cents, for a 19% midpoint increase. Solid revenues through a difficult year have powered strong share appreciation. LE stock has gained a robust 126% over the past 52 weeks. Covering this stock for Craig-Hallum, analyst Alex Fuhrman writes, Lands End defied expectations in 2020 and is well positioned to grow in 2021 and beyond. The company proved its ability to execute in all environments as well as the strength of its branded e-commerce channel, which has grown more than 20% y/y over the past two reported quarters we envision continued e-commerce growth, as 2020s growth was likely the result of market share gains from brick-and-mortar foes rather than 'pantry loading,' while the retail and uniforms channels have potential for substantial growth ahead. Unsurprisingly, Fuhrman rates the stock a Buy, and his price target, at $35, implies ~27% growth potential in the next 12 months. (To watch Fuhrmans track record, click here) Some stocks fly under the radar, and LE is one of those. Fuhrman's is the only recent analyst review of this company, and it is decidedly positive. (See LE stock analysis on TipRanks) To find good ideas for stocks trading at attractive valuations, visit TipRanks Best Stocks to Buy, a newly launched tool that unites all of TipRanks equity insights. Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

Read the original post:
Animal Genetics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product, Genetic Material, and Services and Geography. - Yahoo...

Researchers develop new computational method for studying genetic and environmental interactions – News-Medical.Net

Researchers at Weill Cornell Medicine and Cornell University's Ithaca campus have developed a new computational method for studying genetic and environmental interactions and how they influence disease risk.

The research, published Jan. 7 in The American Journal of Human Genetics, makes the process of finding these interactions much less difficult and demonstrates their importance in determining body mass index and diabetes risk.

"Our study demonstrates that your genes matter and the environment matters and that the interaction of the two can increase risk for disease," said co-senior author, Dr. Olivier Elemento, who is professor of computational genomics in computational biomedicine, professor of physiology and biophysics, associate director of the HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, and director of the Caryl and Israel Englander Institute for Precision Medicine at Weill Cornell Medicine.

Typically, studying gene-environment interactions creates a huge computational challenge, said lead author Andrew Marderstein, a doctoral candidate in the Weill Cornell Graduate School of Medical Sciences whose research was conducted both in Dr. Elemento's lab in New York City and Dr. Andrew Clark's lab in Ithaca, enabling him to have immediate access to computational biology and population health expertise.

"Genotype-environment interaction can be thought of as the situation where some genotypes are much more sensitive to environmental insults than others," said Dr. Clark, co-senior author and Jacob Gould Schurman Professor of Population Genetics in the Department of Molecular Biology and Genetics in the College of Arts & Sciences and a Nancy and Peter Meinig Family Investigator at Cornell University. "These are exactly the cases where changes in the diet or other exposures might have the biggest improvement in health, but only for a subset of individuals."

The millions of genetic variants, or inherited genetic differences found between individuals in a population, and different lifestyle and environmental factors, such as smoking, exercise, different eating habits, can be analyzed for combined effects in numerous ways.

When researchers test for gene-environment interactions, they typically analyze millions of data points in a pairwise fashion, meaning they assess one genetic variant and its interaction with one environmental factor at a time. This type of analysis can become quite labor intensive, said Marderstein.

The new computational method prioritizes and assesses a smaller number of variants in the genome--or the complete set of genetic material found in the body--for gene-environment interactions.

We condensed a problem with analyzing 10 million different genetic variants to essentially analyzing only tens of variants in different regions of the genome."

Andrew Marderstein, Study Lead Author and Doctoral Candidate and Graduate, School of Medical Sciences , Weill Cornell Medicine

While a standard genetic association study might look at whether a single genetic variant could lead to an average change in body mass index (BMI), this study assessed which genetic variants were associated with individuals being more likely to have a higher BMI or lower BMI.

The researchers found that looking for sections of DNA associated with the variance in a human characteristic, called a variance quantitative trait locus or vQTL, enabled them to more readily identify gene-environment interactions. Notably, the vQTLs associated with body mass index were also more likely to be associated with diseases that have large environmental influences.

Another area of study where the new computational method might useful is determining how an individual might respond to a specific drug based on gene-environment interactions, said Marderstein. Analysis of social determinants of health, meaning a person's environmental and social conditions, such as poverty level and educational attainment, is a third area that the researchers are interesting in pursuing, according to Dr. Elemento.

Overall, scientists in the precision medicine field are realizing they can sequence a person's DNA, in addition to assessing environmental factors such air quality and physical activity, to better understand whether the individual is at risk of developing a specific disease.

"The idea down the line is to use these concepts in the clinic," said Dr. Elemento. "This is part of the evolution of precision medicine, where we can now sequence somebody's genome very easily and then potentially analyze all of the variants in the genetic landscape that correlate with the risk of developing particular conditions."

Go here to read the rest:
Researchers develop new computational method for studying genetic and environmental interactions - News-Medical.Net

Press Registration Is Now Open for the 2021 ACMG Annual Clinical Genetics Meeting – A Virtual Experience – PRNewswire

BETHESDA, Md., Jan. 27, 2021 /PRNewswire/ --The ACMG Annual Clinical Genetics Meeting will be a fully virtual meeting in 2021 and continues to provide groundbreaking research and the latest advances in medical genetics, genomics and personalized medicine. To be held April 1316, experience four days of professional growth, education, networking and collaboration with colleagues from around the world and discover what's shaping the future of genetics and genomics, including several sessions on COVID-19. The 2021 ACMG Meeting Virtual Experience is designed to offer a variety of engaging and interactive educational formats and types of sessionsfrom Scientific Sessions and Workshops to TED-Style Talks, Case-based Sessions, Platform Presentations and Short Courses. The 2021 ACMG Meeting Virtual Experience has something for everyone on the genetics healthcare team and will be available to participate in from the convenience of your home or office.

Interview those at the forefront in medical genetics and genomics, connect with new sources, and get story ideas on the clinical practice of genetics and genomics in healthcare today and for the future. Learn how genetics and genomics research is being integrated and applied into medical practice. Topics include COVID-19, gene editing, cancer genetics, molecular genomics, exome sequencing, pre- and perinatal genetics, diversity/equity and inclusion, biochemical/metabolic genetics, genetic counseling, health services and implementation, legal and ethical issues, therapeutics and more.

Credentialed media representatives on assignment are invited to cover the ACMG Annual Meeting A Virtual Experience on a complimentary basis. Contact Kathy Moran, MBA at [emailprotected]for the Press Registration Invitation Code, which will be needed to register at http://www.acmgmeeting.net.

Abstracts of presentations will be available online in February.

A few 2021 ACMG Annual Meeting highlights include:

Program Highlights:

Two Short Courses Available Starting on Tuesday, April 13:

Cutting-Edge Scientific Concurrent Sessions:

Social Media for the 2021 ACMG Meeting Virtual Experience: As the ACMG Annual Meeting approaches, journalists can stay up to date on new sessions and information by following the ACMG social media pages on Facebook,Twitterand Instagramand by usingthe hashtag #ACMGMtg21 for meeting-related tweets and posts.

The ACMG Annual Meeting website has extensive information at http://www.acmgmeeting.net and will be updated as new information becomes available.

About the American College of Medical Genetics and Genomics (ACMG) and the ACMG Foundation for Genetic and Genomic Medicine (ACMGF)

Founded in 1991, the American College of Medical Genetics and Genomics (ACMG) is the only nationally recognized medical society dedicated to improving health through the clinical practice of medical genetics and genomics and the only medical specialty society in the US that represents the full spectrum of medical genetics disciplines in a single organization. The ACMG is the largest membership organization specifically for medical geneticists, providing education, resources and a voice for more than 2,400 clinical and laboratory geneticists, genetic counselors and other healthcare professionals, nearly 80% of whom are board certified in the medical genetics specialties. ACMG's mission is to improve health through the clinical and laboratory practice of medical genetics as well as through advocacy, education and clinical research, and to guide the safe and effective integration of genetics and genomics into all of medicine and healthcare, resulting in improved personal and public health. Four overarching strategies guide ACMG's work: 1) to reinforce and expand ACMG's position as the leader and prominent authority in the field of medical genetics and genomics, including clinical research, while educating the medical community on the significant role that genetics and genomics will continue to play in understanding, preventing, treating and curing disease; 2) to secure and expand the professional workforce for medical genetics and genomics; 3) to advocate for the specialty; and 4) to provide best-in-class education to members and nonmembers. Genetics in Medicine, published monthly, is the official ACMG journal. ACMG's website (www.acmg.net) offers resources including policy statements, practice guidelines, educational programs and a 'Find a Genetic Service' tool. The educational and public health programs of the ACMG are dependent upon charitable gifts from corporations, foundations and individuals through the ACMG Foundation for Genetic and Genomic Medicine.

Kathy Moran, MBA[emailprotected]

SOURCE American College of Medical Genetics and Genomics

http://www.acmg.net

See the original post:
Press Registration Is Now Open for the 2021 ACMG Annual Clinical Genetics Meeting - A Virtual Experience - PRNewswire

Digbi Health’s gut-microbiome and genetic-based obesity management program now allows 60,000 Doctors and Providers in Blue Shield of California’s…

MOUNTAIN VIEW, Calif., Jan. 26, 2021 /PRNewswire/ --Digbi Health, the first company with a clinically proven genetics and gut-microbiome based program to safely and sustainably treat and manage obesity and associated inflammatory gut, skin and cardiometabolic health issues, is now available to Blue Shield of California members, as a fully covered program, on the health plan'sWellvolution platform.

It's the first time over 60,000 physicians and clinicians practicing in California in the Blue Shield of California's network can prescribe a weight-loss program personalized on a person's genetic, gut microbiome and lifestyle. Through the Digbi Health solution, patients are supported by a team of caregivers, led by a physician and care experts trained in nutrition, cognitive behavior therapy, genetics and gut microbiome. Blue Shield of California offers access to Digbi Health through the Wellvolution platform as a fully covered program to members who qualify.

The Digbi Health Precision Care Network (PCN) is a network of physicians practicing precision medicine. As part of that network, physicians get marketing resources to educate their patients about Digbi Health on the Wellvoution platform, access to their patient's dashboard, with patient approval, and additional support from the Digbi Health care concierge team to support their patients between visits to help improve patient outcomes. Digbi Health program members without a physician can also get referred to a specialist in the PCN.

"The development of cardiovascular disease is a matter of genetic predisposition and gut microbiome composition interacting with acquired conditions, and factors such as diet, exercise, and exposure to damaging elements," said Cynthia Thaik, MD. Harvard-trained cardiologist at the Holistic Healing Heart Center and Digbi Health PCN member.

"I have already prescribed Digbi Health to a patient covered by Blue Shield of California for pre-diabetes and hypertension," she added.

Blue Shield of California is taking the lead on personalized and preventive care for their members.

Among participants participating in Wellvolution:

"We are an innovative telehealth company that supports overburdened physicians by redefining care for 100 million Americans who struggle under one-size-fits-all digital health programs, weight loss diets and stigma of "poor self-control" while fighting obesity and associated inflammatory comorbidities," said Ranjan Sinha, CEO and founder of Digbi Health.

About Digbi Health Precision Care NetworkOur network includes healthcare providers from all specialties and practice settings throughout the U.S., including bariatric surgeons, internal medicine, family medicine, chiropractitioners, nutritional experts, and others in the lifestyle and integrative medicine space using genetics, nutrigenomics, gut microbiome and lifestyle risk to treat the complexity of the multifactorial disease of obesity and its' related medical conditions. Providers can sign-up to the network at no charge here.

About Digbi HealthDigbi Health is a first-of-its-kind precision digital therapeutics company that offers a prescription-grade digitally enabled personalized obesity and obesity related gut, skin disorders, hypertension and other cardiometabolic health management programs based on an individual's gut biome, genetic risks, blood markers, and lifestyle factors. Digbi Health and members of its physician network are committed to empowering people to take control of their own health and wellness. Digbi Health is prescribed by doctors, health care providers, and insurance companies.

SOURCE Digbi Health

See more here:
Digbi Health's gut-microbiome and genetic-based obesity management program now allows 60,000 Doctors and Providers in Blue Shield of California's...

Animal Genetics Market Forecast to 2027 – COVID-19 Impact and Global Analysis By Product, Genetic Material, and Services and Geography. -…

New York, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Animal Genetics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product, Genetic Material, and Services and Geography." - https://www.reportlinker.com/p06010023/?utm_source=GNW However, the market is likely to get impacted by the limited number of skilled professionals in veterinary research and stringent government regulations for animal genetics during the forecast period.

The branch of genetics that deals with the study of gene variation and inheritance in companion, domestic and wild animals is called as animal genetics.Animal genetics are used for genetic trait testing, DNA testing, and genetic disease treatment.

Animal genetics is one of the best mainstays of livestock development (alongside animal nutrition, animal health, and husbandry concerns such as housing). According to the Food and Agriculture Organization of the United Nations, it is a wide field, ranging from characterization to maintenance to genetic improvement, and involves activities at local, national, regional, and global scales.Increasing population and rapid urbanization across the world has resulted in growing preference for animal derived food products such as dairy products and meat that contain high protein.The demand for animal derived proteins and food products, which, in turn drives the growth of animal genetics market.

Growing focus on developing superior animal breeds using genetic engineering to obtain high reproduction rates for large-scale production of modified breeds is expected to drive animal genetics market during the forecast period.Based on product, the market is segmented into poultry, porcine, bovine, canine, and others.The porcine segment held the largest share of the market in 2019, whereas the same segment is anticipated to register the highest CAGR in the market during the forecast period.

Growth of this segment is attributed to rise in production of porcine and increase in pork consumption across the globe.Based on genetic material, the market is segmented into semen and embryo. The embryo segment held the largest share of the market in 2019, and the semen segment is anticipated to register the highest CAGR in the market during the forecast period.COVID-19 pandemic has become the most significant challenge across the world.This challenge would be frightening, especially in developing countries across the globe, as it may lead to reducing imports due to disruptions in global trade, which further increases the shortages of meat and dairy product supplies, resulting in a considerable price increase.

Asian countries such as China, South Korea, and India are severely affected due to COVID-19 outbreak.The World Health Organization, Food and Drug Administration, American Pet Products Association, American Veterinary Medical Cattle Health, and Welfare Group for Disease Control and Prevention are among the major primary and secondary sources referred for preparing this report.Read the full report: https://www.reportlinker.com/p06010023/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Go here to see the original:
Animal Genetics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product, Genetic Material, and Services and Geography. -...

A&M team’s research on rabbits leads to genetic breakthrough – Texas A&M The Battalion

Even with shared ancestry, domesticated and wild animals look different, but according to a recent study, their differences stretch far beyond their appearances.

In a study led by Leif Andersson, a professor at the Texas A&M College of Veterinary Medicine & Biomedical Sciences, or CVMBS, he and his team discovered there were changes in gene expression between the brains of domesticated and wild rabbits, as mentioned in Texas A&M Today.

Domestication is a very important development which happened during human history so there has been a lot of interest to try to understand what genetic changes have happened during domestication, Andersson said. So, how could we transform a wild species into a domesticated species?

Andersson said his team chose rabbits rather than other domesticated animals, like dogs and goats, as rabbits were more recently domesticated which makes genetic and structural changes more evident.

The team started by DNA sequencing wild rabbits and domestic rabbits from different breeds and then compared the different sequences in their genomes, Andersson said.

The most consistent differences we saw between wild and domestic was changes in gene frequencies in genes related to brain development, Andersson said.

The next step was looking at the morphology in the rabbits brain. Andersson said they found structural changes in the brain, specifically in the amygdala, which is the part of the brain involved in how animals respond to fear. Ultimately, the expression of dopamine changed in the amygdala, said Andersson.

It turned out that domestic rabbits amygdala had shrunk in size, Andersson said. There is a functional difference in how the amygdala functions in the domestic rabbit.

Todd OHara, the Veterinary Integrative Sciences department head, said Andersson did a great job linking genetics with function, as he looked at how genes turned on and off and then linked it to morphological processes.

In some cases in genetic studies, we often end up with what we call transcriptomic data, OHara said. What we see there is just results from what genes were upregulated and which genes are downregulated, and then were left with that. In this case, they were able to make linkages..

The teams findings make a significant contribution to the understanding of how the changes in brain architecture and gene expression affect animal behavior and lead to altered fear responses, Brian Davis, a professor in the CVMBS, said.

Since dopamine is intimately involved with the sense of well-being and reward behavior, this finding is consistent with the physiological response of reduced fear, Davis said.

While the data-intensive study involved a large amount of mathematical processing, Andersson and his teams diligence ultimately led to a significant finding.

It gives the first clue to what type of changes in gene expression is associated with the development of tameness, so it would be very interesting to follow up with this in other species and see if this is a common theme, said Andersson. Its a good step towards understanding [how] domestication has affected brain function in domestic animals.

View original post here:
A&M team's research on rabbits leads to genetic breakthrough - Texas A&M The Battalion

Cambridge-based Sano Genetics gets a capital injection of 2.5M to offer free at-home DNA testing kits for those affected by Long COVID – UKTN (UK…

Sano Genetics, a Cambridge-based startup with an aim to support personalised medicine research by increasing participation in clinical trials and guiding patients all through the process has recently grabbed 2.5M seed funding from a slew of investors.

The financing round was led by Episode1 Ventures along with participation from Cambridge Enterprise, Seedcamp, January Venture and a slew of angel investors from UK, Europe and US. Previously, Sano Genetics raised 500K pre-seed funding in 2018.

The latest funding round includes a grant from Innovate UK, which will cover the cost of free at-home DNA testing kits for 3,000 people affected by Long Covid. Also, the investment will be used for the continuous development of its private-by-design tech platform, which gives full control and transparency for users regarding how and where their personal data is used by researchers.

Chief operating officer of Sano Genetics, Charlotte Guzzo, explained: This tranche of funding will help us further develop the end-to-end experience for the many people keen to contribute to personalised medical research, including clinical trials of potentially life-changing medicines and, in doing so, improve the outlook for people living with chronic and often debilitating conditions.

Besides the funding, Sano Genetics partnered with Genomics England to develop software that will be used for national-scale precision medicine initiatives. It will improve the participants experience in research. This software will add a vital layer of information reported directly by participants including daily symptom tracking or via wearable devices monitoring activity or sleep.

Sano Genetics was founded in 2017 by Charlotte Guzzo, Patrick Short and William Jones while pursuing genomics at Cambridge University. They observed, first hand, the high failure rate of clinical trials and the poor experience for those taking part. The startups digital platform and at-home genetic testing capabilities are already empowering greater participation in crucial research into multiple sclerosis, ankylosing spondylitis, NAFLD, and ulcerative colitis. Also, it plans for a research programme for Parkinsons disease for late this year.

Original post:
Cambridge-based Sano Genetics gets a capital injection of 2.5M to offer free at-home DNA testing kits for those affected by Long COVID - UKTN (UK...

‘Sticking with what we have and selecting superior genetics seen as the way forward’ – Agriland

Sticking with what we have and selecting for superior genetics rather than importing genetics from New Zealand is seen as the way forward for Irish sheep farmers, according to Nicola Featherstone.

Nicola was speaking at the first of two virtual Teagasc Sheep Conferences which were held yesterday evening (Tuesday, January 26).

Teagasc Walsh Scholar Nicola gave an update on the INZAC trial in Teagasc Athenry, Co. Galway, which compares 1-star and 5-star Irish ewes with elite New Zealand ewes.

One question put to Nicola during yesterdays session was how relevant did she think New Zealand sheep are in an Irish context and if they are far superior to what we have here in Ireland?

She explained: During my time in New Zealand, along with visiting a number of farms, I also collaborated with a consultancy company and over there we generated a model and that model looked at all different scenarios that we could put into practice here in Ireland.

For example, whether or not we would look at importing New Zealand genetics or should we stick with what we have here in Ireland or maybe a mixture of both.

From looking at the results, it showed that the benefit, in terms of genetics and economics, would be greater for the Irish industry if we stuck with what we have rather than importing New Zealand genetics, as long as we source our genetics from more progressive breeders.

So, essentially, it means that we need commercial farmers to drive demand towards sourcing animals of superior genetics.

If we stick with the system we have which identifies the elite animals, in terms of being 5-stars, then this is the best way forward for Irish sheep farmers.

RELATED STORIES

The rest is here:
'Sticking with what we have and selecting superior genetics seen as the way forward' - Agriland

Partners in Crime: Genetic Collaborator May Influence Severity of the Rare Disease, NGLY1 – Newswise

Newswise In 2012, four-year-old Bertrand Might became the first-ever patient diagnosed with a rare genetic disorder called N-glycanase (NGLY1) deficiency. The discovery of this condition and Bertrands diagnosis allowed doctors to look for other children with the same genetic defect. Since then, more than 60 additional patients have been found. The disease affects every system of the body and is characterized by low muscle tone, seizures, developmental delays, and an inability to produce tears.

Sadly, Bertrand passed away in October at the age of 12. Although his life was cut short, his legacy will benefit children around the world. Through their website, NGLY1.org, Bertrands parents collect and share a wealth of research and family stories to help educate and inform the community. As more patients have been identified, its become apparent that even though the same gene is deactivated in all of them, their symptoms and severity of disease vary widely.

Geneticist Clement Chow, Ph.D., assistant professor in the Department of Human Genetics at University of Utah Health, studies NGLY1 deficiency in the fruit fly, Drosophila melanogaster. To understand how the disease symptoms can vary so much, he and his colleagues are hunting for other genes that interact with NGLY1. In a paper published in eLife, Chow reports that his lab has found that one of these interacting genes moderates disease severity. The gene, called ncc69, has a human counterpart called NKCC1. Their experiments showed that NGLY1 chemically modifies NKCC1. Studying this interaction could help illuminate how NGLY1 deficiency affects the body.

Common diseases, such as heart disease or cancer, arise from a combination of many genetic and environmental causes, while rare diseases are more likely caused by a single gene. But every single-gene disease occurs against the individual patients unique genetic backdrop, a patchwork of different genetic variants inherited from both parents. Children with NGLY1 deficiency start experiencing serious symptoms early in life, suggesting that environmental differences, such as diet, arent a key factor. More likely, differences in their other genes are influencing the clinical course of the disease.

To search for genes that work together with NGLY1, the researchers needed to use flies with varied genetic backgrounds. Laboratory flies, however, are inbred to be genetically identical. To approximate the natural genetic diversity found in humans, Chow turned to a resource called the Drosophila Genetic Reference Panel. Its a collection of 200 different fruit fly lines, all bred from the same original populationbut each one is just a bit different from the others.

Its like if you sampled 200 Northern Europeans, Chow says. Theyd share lots of genetic variants, but lots of differences as well.

In each strain of flies, Chow and his research team swapped in a non-working copy of the NGLY1 gene, then looked for differences in survival. Strikingly, the flies genetic background heavily influenced how long the young flies could survive without NGLY1.

These flies all carry the same disease mutation thats supposed to cause the same disease, Chow says. Yet here were seeing that, in some genetic backgrounds, they cant live at all with NGLY1 deficiency. And in some genetic backgrounds, all the flies survived to adulthood.

The researchers analyzed the genes that varied among the flies that survived and those that died, coming up with a list of candidate genes that could be playing a role. They began studying one of these candidates, NKCC1, and soon switched from flies to mice.

When we hit a wall in what we could do with flies, we decided to turn to the mouse model to try to fully characterize what NKCC1 and NGLY1 are doing to interact with each other, Chow says.

In cells from mice, the researchers discovered that the NKCC1 protein assumes its correct shape through glycosylation, a chemical process that tacks sugar molecules onto the protein. NGLY1 acts to remove these sugar molecules from specific targets.

In the absence of NGLY1, Chow found, NKCC1 was overloaded with extra sugars, reducing activity in the cell by 50%. Without NGLY1, NKCC1 cant do its job properly, which is to move fluids and ions out of the cell.

While application to human disease is still a long way off, the role of NKCC1 makes sense in terms of the symptoms seen in NGLY1 patients. One of the hallmark features of NGLY1 deficiency is the inability to make tears, sweat, and saliva. It turns out that patients who lack NKCC1 also have this symptom. NKCC1 is active in salivary glands, sweat glands, and tear ducts, which supports the idea that the molecule plays a role in causing the symptoms.

This was all discovered through a genetic screen in Drosophila, Chow says. This really speaks to the power of using simpler model organisms, especially for rare diseases, where you want to get results faster.

-Written by Caroline Seydel

# # #

In addition to U of U Health scientists, contributors include researchers from the University of Pittsburgh, The Jackson Laboratory and the Veterans Affairs Salt Lake City Health System.

The study published as A Drosophila screen identifies NKCC1 as a modifier of NGLY1 deficiency and was supported by the National Institutes of Health, Might Family, and the Glenn Foundation for Medical Research.

View original post here:
Partners in Crime: Genetic Collaborator May Influence Severity of the Rare Disease, NGLY1 - Newswise

Mange in Yellowstone wolves reveals insights into human scabies and conservation biology – Princeton University

Before wolves were reintroduced to Yellowstone National Park in the mid-1990s, they were vaccinated for common diseases and treated for any parasite infections they already carried. As a result, the first few generations of wolves were relatively disease-free, but over the years, various diseases have found their way into the population.

Both of these Yellowstone wolves display the hair loss and skin lesions associated with mange. By analyzing 25 years of wolf observations and geneticsamples from 408 Yellowstone wolves, a Princeton-led research team found that genetics playa role in the severity of the mite-borne disease.Theyfound support for the "monoculture theory":wolves with severe mange, like the one on the left, tendto have less genetic variation than wolves with mild symptoms, as seen on the right.

Photos by Rebecca Raymond/National Park Service and Dan Stahler/National Park Service

Sarcoptic mange, caused by the microscopic mite Sarcoptes scabiei, first crawled its way into the reintroduced Yellowstone wolves in 2007. Mange is characterized by itchy skin lesions and hair loss, but there is huge variation between individuals in terms of how sick wolves actually become some experience mild mange symptoms and are able to clear the mites within a few months, while others experience massive hair loss, emaciation andsecondary bacterial infections, and eventually die of the disease. Mange isnt exclusively a disease of wolves, either. Sarcoptic mange mites infect more than 100 different mammalian species, including humans (where the disease is better known as scabies), and similar inter-individual variation in disease severity occurs in all of these host species.

Little is known about what causes thevariation in manginess, but a team of researchers, led by then-Princeton graduate student Alexandra DeCandia, sought to uncover this mystery. Their study, published in Evolutionary Applications, brings together schools of thought from molecular biology, disease ecology and conservation biology.

Genetics provide us with a really powerful tool for understanding wildlife health and conserving at-risk species, said DeCandia, who completed her Ph.D. in 2020 and is now a postdoctoral researcher at the Smithsonian Conservation Biology Institute. We can learn more about the causes of disease, the short- and long-term effects on individual animals and populations, and how best to respond as wildlife biologists and managers. For widespread diseases like mange, we can even gain insights into common processes that affect other host species including our own for a larger-scale One Health perspective that ultimately improves both human and wildlife health.

Though the researchers focused on wolves, the genetic pathways they uncovered will help pave the way for research into human scabies, which infects some 200 million people.

The premise of their research is based on a phenomenon known in agriculture as the monoculture effect, which predicts that the ability of individuals and populations to combat disease is related to genetic diversity. Individuals with higher genetic diversity are more resistant to disease, or more likely to experience mild disease, because they have more genetic tools with which to fight off diverse pathogens. Similarly, at the population scale, populations with higher genetic diversity may be less likely to experience disease outbreaks and more likely to survive outbreaks if they do occur.

Think of an agricultural monoculture. In a field of genetically identical bananas, for example, if a parasite is capable of infecting one banana tree, it has the tools needed to infect all of the banana trees. Of course, populations of wild animals are never monocultures, but they do vary in the amount of genetic variation they contain. And if the population in question originates from a small number of individuals, the amount of genetic variability available may be limited. Such is the case with the reintroduced wolves of Yellowstone National Park.

Leveraging over 25 years of wolf observational data and genetic samples from 408 individual wolves, the research team led by DeCandia and her adviser Bridgett vonHoldt, an associate professor in ecology and evolutionary biology at Princeton Universitylooked for patterns in overall genetic diversity associated with mange: Is the degree of individual-level genetic diversity associated with disease severity? Are specific genes involved? How did the introduction of mange impact genetic diversity at the population level? Using their years of observations, the researchers analyzed the genetic results in the context of broader wolf biology to see how genetic variation interacts with other factors behavioral, environmental and demographic to determine mange severity.

In individual wolves, the researchers found support for their hypothesis: wolves with severe mange tended to have less genetic variation than wolves with mild symptoms. Additionally, the study identified 410 genetic variants that are significantly associated with mange severity. These variants are known to play roles in inflammation, immunity and skin barrier integrity, and could potentially be molecular targets for mange or scabies treatment in other host species.

Professor Bridgett vonHoldt (center) isflanked by her graduate studentsin Yellowstone National Park in this photo from January 2019. From left: Dhriti Tandon, Elizabeth Heppenheimer, Alexandra DeCandia and Christopher Lawrence.

Photo by Axel Haenssen, Research Computing, Office of Information Technology

The researchers found that the best model of mange severity included not only genetic variation, but also took into account the age and breeding status of the wolf in question, and the season. Wolves tend to experience more severe mange in winter, when it is more difficult to thermoregulate; older wolves tended to have worse mange than younger wolves, although pups were not included in the study; and non-breeding wolves tend to be more mangy than breeders (though the direction of causation here is unclear it could be their manginess that prevents them from breeding).

At the population scale, overall genetic diversity has decreased in the Yellowstone wolves over the years.

Such changes in diversity are not unexpected, said vonHoldt, the senior author on the study. We have found that genetic diversity has been preserved well through mechanisms that shape pack and breeding pair formations. This recent opportunity to incorporate immunity and mange prevalence has really given us insights into the genetic dynamics shaped additionally by disease in a social carnivore.

Interestingly, gene variants that are associated with more severe mange have become less common in the population since mange emerged in 2007. This finding indicates that the disease is placing strong evolutionary selection pressure on the wolf population, weeding out those wolves most likely to succumb todeath from mange.

The findings are also significant for conservation biology, since maintaining healthy and genetically diverse individuals is one of the keys to conservation.

Conservation genetics has traditionally relied on a handful of genetic markers to inform captive breeding or wild population management, DeCandia said. For species of conservation concern, this research highlights the importance of examining both summary metrics of genome-wide variation and specific genes associated with disease.

In addition to DeCandia and vonHoldt, the other authors involved in the study were Edward Schrom, a 2020 graduate alumnus who is now a postdoctoral researcher at the National Institutes of Health; Ellen Brandell, a postdoctoral researcher at the University of Wisconsin-Madison; and Daniel Stahler, the lead wolf biologist at Yellowstone National Park.

Sarcoptic mange severity is associated with reduced genomic variation and evidence of selection in Yellowstone National Park wolves (Canis lupus), by Alexandra DeCandia, Edward C. Schrom, Ellen Brandell, Daniel R Rahler, and Bridgett vonHoldt, was published Sept. 10, 2020, in Evolutionary Applications (DOI: 10.1111/eva.13127). This work was supported by Princeton University's Department of Ecology and Evolutionary Biology and Center for Health and Wellbeing; the National Science Foundation (DEB0613730, DEB-1245373and DGE1656466); the Yellowstone Park Foundation (now Yellowstone Forever); and key donors, especially Annie and Bob Graham, Valerie Gates, and Frank and Kay Yeager.

Continued here:
Mange in Yellowstone wolves reveals insights into human scabies and conservation biology - Princeton University